MYC and head and neck squamous cell carcinoma: In colon and head and neck squamous cell carcinomas, overexpression of CIP2A leads to the potentiation of MYC S62 phosphorylation, the PP2A target, thereby inhibiting proteolysis and resulting in increased oncogenic MYC protein stability (31, 32).